THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE
ANNUAL REPORT AND AUDITED FINANCIAL STATEMENTS
YEAR ENDED 31 DECEMBER 2020
Charity No 264136
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE ANNUAL REPORT AND FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 2020
The Trust was established under a trust deed in April 1972 in order to provide relief to patients at the centre and to support the work of the centre.
The Trust is a registered charity.
| President: | The Lord Mayor of Bristol |
|---|---|
| Officers | |
| Chair | Mrs O Grogono |
| General Secretary | Mrs E Pritchard |
| Treasurer | Mrs CM Owen |
| Trustees | Mr S Blake - appointed 10 March 2020 |
| Mrs J Breach | |
| Mrs A Carlton | |
| Mr GJ Clements | |
| Dr M Cobby - appointed 10 March 2020 | |
| Mrs G Creese - appointed 15 January 2020 | |
| Dr G Crichton - appointed 15 January 2020 | |
| Mrs N Day - appointed 15 January 2020 | |
| Mrs O Grogono | |
| Mr S Moorlen | |
| Mrs P Murphy - appointed 10 March 2020 | |
| Mrs CM Owen | |
| Mrs S Sims - appointed 15 January 2020 | |
| Mrs A Thomas | |
| Advisors | |
| Bankers | National Westminster Bank plc |
| Bristol City Office | |
| Auditors | Elliott Bunker Limited |
| 1st Floor 61 Macrae Road | |
| Ham Green | |
| Bristol | |
| BS20 0DD | |
| Stock brokers | Alpha Portfolio Management |
| 1 The Square | |
| Temple Quay | |
| Bristol | |
| Registered Office | Bristol Haematology and Oncology Centre |
| Horfield Road | |
| Bristol | |
| Telephone | 0117 342 3432 |
Page 1
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE ANNUAL REPORT AND FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 2020
Trustees’ report
The trustees present their report and the audited financial statements for the year ended 31 December 2020.
The financial statements have been prepared in accordance with the Statement of Recommended Practice: Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) and the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS102) and the Charities Act 2011 and UK Generally Accepted Practice as it applies from 1 January 2015
Constitution and objects
The Trust was constituted under the model deed for Friends of Hospitals. A revised constitution was adopted in September 2006. The principal object of the Trust as set out in the constitution is to offer relief to patients and former patients and to support the work of the Centre.
During the year, the charity’s main objectives continued to be those of fundraising and management of the investment portfolio, enabling financial support to be given to the Bristol Haematology and Oncology Centre in respect of specific projects.
The trustees confirm that they have referred to the guidance contained in the Charity Commissioners’ general guidance on public benefit when reviewing the Trust’s aims and objectives and in planning future funding of the Centre.
Structure and organization
The Trust is unincorporated and is a registered charity. The trustees in office during the year and at the date of this report are as set out on page 1.
A main committee as set out in the constitution manages the Trust. Meetings are held quarterly and are attended by representatives from the hospital. Trustees are invited to join the committee by existing trustees or by recommendations from hospital staff. In addition to the main committee there are two subsidiary committees. The subsidiary committees operate in accordance with the constitution and report to the main committee.
The investment committee has responsibility for investing the Trust’s reserves and is chaired by Mr JRG Miles. The following trustees also serve on the committee: Mr GJ Clements, Mrs J Breach, Mrs O Grogono and Mrs CM Owen. The house committee is concerned with patient amenities and is chaired by Mrs O Grogono. The following trustees also serve on the committee Mrs A Thomas, Mrs N Day, Mrs S Sims, Mrs G Creese and Dr G Crichton.
Review of activities and future developments
During the year the Trust has continued to raise money to benefit the patients of The Bristol Haematology and Oncology Centre. The fundraising is largely carried out by volunteers and the trustees are very grateful to the many volunteers who carried out fund raising activities on behalf of the Trust during the year.
The Trust has and will continue to support the work of the hospital by financing various capital and research projects undertaken by the hospital and Bristol University.
As a result of the global pandemic caused by Covid19 the income of the Trust has fallen as social isolation has restricted the funding raising activities of our supporters.
Financial activities and affairs
There have been no changes in the policies of the Trust during the year.
In March 2020, as a result of the global pandemic caused by Covid19 the value of our share portfolio fell by 11% in a month. Thanks to the help and advice of the stockbroker and the investment committee, the portfolio has recovered over the second half of the year in improved market conditions. Sales of investments in the year have made a profit compared to cost of £164,700 (2019: £242,728).
During the year incoming resources from fundraising, donations and legacies and investment income totalled £170,298 (2019: £558,649), and expenditure on specific projects amounted to £192,089 (2019: £334,147). After deducting the charity’s operating expenses and allowing for the realised and unrealised investment revaluation surpluses the resulting deficit for the year was £220,888 (2019: surplus £736,113).
At the year end the Trust’s balance sheet showed total funds of £4,790,864 (2019: £5,011,752) of which £4,743,175 (2019: £4,929,670) were unrestricted funds.
Page 2
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE ANNUAL REPORT AND FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 2020
Reserves
The unrestricted fund represents the accumulated surpluses from previous years. The policy of the Trust is to build these reserves by judicious management of investment assets to maximise the income available for future years. The expenditure on charitable objectives each year depends on the requests from the hospital management. All expenditure is approved by the hospital management before being presented to the Trustees at the quarterly meetings. The level of reserves is reviewed at the meetings and decisions regarding expenditure is made by the Trustees having given consideration to available reserves and funds already committed. The Trustees keep sufficient reserves to support any long term commitments to the hospital.
At the year end free reserves have been calculated at £507,178 (2019:£324,719).
The restricted funds represent funds held for specific purposes as set out in note 11 to the financial statements
During 2019 the Trust received a legacy of £120,213 in addition to the legacy received in 2018 of £150,000. The testatrix wished this legacy to be used for research into the treatment of sarcoma. The centre has no ongoing research into this condition and it was therefore agreed with the executors that the legacy of £270,213 should be donated to Sarcoma UK a registered charity that is conducting relevant research.
Trustees’ responsibility for the accounts
Law applicable to charities in England and Wales requires the trustees to prepare financial statements for each financial year, which give a true and fair view of the financial activities of the charity during the year and of its state of affairs at the end of the year. In preparing those financial statements the trustees are required to:
-
Select suitable accounting policies and apply them consistently;
-
Make judgments and estimates that are reasonable and prudent;
-
Observe the methods and principles in the Charities SORP
-
State whether applicable accounting standards and statements of recommended practice have been followed, subject to any material departures disclosed and explained in the financial statements; and; 5. Prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Charity will continue in operation.
The trustees are responsible for keeping proper accounting records, which disclose with reasonable accuracy at any time the financial position of the charity and which enable them to ensure that the financial statements comply with section 130 of the Charities Act 2011 and general law. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Risk management
The trustees have assessed the major risks to which the Trust is exposed, in particular those related to the operations and finances of the Trust, and are satisfied that systems are in place to mitigate exposure to such risks.
Investment policy
The trustees have the power to invest in such assets as they see fit.
The investment committee meets at least three times a year to review the investment portfolio and the cash requirements of the Trust. For the last few years the Trust’s income has exceeded its requirements and as a result the investment strategy is to invest in low and medium risk investments to balance capital appreciation with a reasonable income flow to enable the trust to meet its objectives.
Post Balance Sheet Events
Since the year end there has been a further national lock down caused by the outbreak of COVID-19.
Due to the continued social restrictions, income in 2021 is likely to continue to be restricted as fund raising events cannot be held. In addition, reorganisation of clinics within the hospital has led to more requests for equipment. The Trustees are confident that there will be no lasting effects on the financial health of the charity.
Approved by the trustees on 13 January 2022 and signed on their behalf by:
Mrs Caroline Owen
Trustee
Page 3
INDEPENDENT AUDITOR’S REPORT TO THE TRUSTEES OF THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE
Opinion
We have audited the financial statements of The Friends of Bristol Haematology and Oncology Centre (the “Charity”) for the year ended 31 December 2020 which comprise the Statement of Financial Activities, Balance Sheet, Statement of Cash Flows and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102: The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion, the financial statements:
-
give a true and fair view of the state of the Charity’s affairs as at 31 December 2020 and of its income and expenditure for the year then ended;
-
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice;
-
have been prepared in accordance with the requirements of the Charities Act 2011.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the Charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
We have nothing to report in respect of the following matters in relation to which the ISAs (UK) require us to report to you where:
- the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is not appropriate; or
• the trustees have not disclosed in the financial statements any identified material uncertainties that may cast significant doubt about the Charity’s ability to continue to adopt the going concern basis of accounting for a period of at least twelve months from the date when the financial statements are authorised for issue.
Other information
The trustees are responsible for the other information. The other information comprises the information included in the annual report other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the Charity and its environment obtained in the course of the audit, we have not identified material misstatements in the Trustees’ Annual Report.
Page 4
We have nothing to report in respect of the following matters in relation to which the Charities Act 2011 requires us to report to you if, in our opinion:
-
sufficient accounting records have not been kept;
-
the financial statements are not in agreement with the accounting records and returns; or
-
we have not obtained all the information and explanations necessary for the purposes of our audit.
Responsibilities of the trustees
As explained more fully in the trustees’ responsibilities statement set out on page 3, the trustees are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as they determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the trustees are responsible for assessing the Charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the Charity or to cease operations, or have no realistic alternative but to do so.
Our responsibilities for the audit of the financial statements
Key audit matters: our assessment of risks of material misstatement
Key audit matters are those matters that in our professional judgement were of most significance in the audit of the financial statements and include the most significant assessed risks of material misstatement (whether or not due to fraud) identified by us, including those which had the greatest effect on the allocation of resources in the audit, and directing the efforts of the engagement team. There are no key areas identified as the audit is very low risk with normal audit procedures adequate in all audit areas.
We agreed to report to the board of trustees any corrected or uncorrected identified misstatements
Identifying and reporting of risks of material misstatement due to fraud
To identify risks of material misstatement due to fraud we assessed events or conditions that could indicate an incentive or pressure to commit fraud or provide an opportunity to commit fraud. Our risk assessment procedures included:
(i) enquiring of the trustees and inspection of key papers provided to those charged with governance as to high level policies and procedures to prevent and detect fraud.
(ii) reviewing the minutes of trustees' meetings.
We communicated identified fraud risks throughout the audit team and remained alert to any indications of fraud throughout the audit.
As required by Auditing Standards, and taking into account our overall knowledge of the control environment, we performed procedures to assess the risks of management override of controls. To address the pervasive risk as it related to management override of controls, we reviewed material journal entries and agreed these to supporting documentation where appropriate.
Identifying and responding to risks of material misstatement due to non-compliance with laws and regulations
We identified areas of laws and regulations that could reasonably be expected to have a material effect on the financial statements from our general commercial and sector experience and through discussion with the Treasurer. As the charity is regulated, our assessment of risks involved gaining an understanding of the control environment including the entity's procedures for complying with regulatory requirements.
Page 5
We communicated identified laws and regulations throughout our team and remained alert to any indications of non-compliance throughout the audit.
Auditing Standards limit the required audit procedures to identify non-compliance with these laws and regulations to enquiry of management and trustees and inspection of regulatory and legal correspondence, if any. Therefore, if any breach of operational regulations is not disclosed to us or evident from relevant correspondence, an audit will not detect that breach.
Limitations to the ability of the audit to detect fraud or breaches of laws and regulation
Owing to the inherent limitation of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements, even though we have properly planned and performed our audit in accordance with auditing standards. For example, the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely the inherently limited procedures required by Auditing Standards would identify it.
In addition, as with any audit, there remained a higher risk of non-detection of fraud, as this may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal controls. Our audit procedures are designed to detect material misstatement, and therefore we are not responsible for preventing non-compliance or fraud and cannot be expected to detect non-compliance with all laws and regulations.
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.
Use of our report
This report is made solely to the Charity's trustees, as a body, in accordance with section 144 of the Charities Act 2011 and the regulations made under section 154 of that Act. Our audit work has been undertaken so that we might state to the Charity's trustees those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Charity's trustees as a body, for our audit work, for this report, or for the opinions we have formed.
Paul Cridland
Elliott Bunker Ltd (Chartered Accountants and Statutory Auditor) 1[st] Floor, 61 Macrae Road Eden Business Park Ham Green Bristol BS20 0DD 13 January 2022
Date
Page 6
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE STATEMENT OF FINANCIAL ACTIVITIES YEAR ENDED 31 DECEMBER 2020
| Income and endowments from Donations and legacies 3 Other trading activities 4 Investment income 5 Total Expenditure on Raising funds 6 Charitable activities 7 Total Net income Transfers Gross transfers between funds Net income before other recognised gains and losses OTHER RECOGNISED GAINS (Losses)/gains on investments Net movement in funds Total funds brought forward Total funds carried forward Note Realised gains on disposals Unrealised gains/(losses) on revaluations |
Unrestricted fund £ 20,317 2,096 93,978 116,391 1,061 103,098 104,159 12,232 (50,399) (38,167) 164,700 (313,028) (186,495) 4,929,670 4,743,175 |
Restricted funds £ 53,887 0 20 53,907 0 138,699 138,699 (84,792) 50,399 (34,393) 0 0 (34,393) 82,082 47,689 2020 |
Total £ 74,204 2,096 93,998 170,298 1,061 241,797 242,858 (72,560) 0 (72,560) 164,700 (313,028) (220,888) 5,011,752 4,790,864 |
Unrestricted fund £ 203,535 32,571 118,596 354,702 14,393 77,953 92,346 262,356 0 262,356 242,728 335,033 840,117 4,089,553 4,929,670 |
Restricted funds £ 203,748 0 199 203,947 0 307,951 307,951 (104,004) 0 (104,004) 0 0 (104,004) 186,086 82,082 2019 |
Total £ 407,283 32,571 118,795 |
|---|---|---|---|---|---|---|
| 558,649 | ||||||
| 14,393 385,904 |
||||||
| 400,297 | ||||||
| 158,352 0 |
||||||
| 158,352 242,728 335,033 |
||||||
| 736,113 4,275,639 |
||||||
| 5,011,752 |
All activities relate to continuing operations.
All gains and losses recognised in the year are included in the Statement of Financial Activities.
Page 7
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE BALANCE SHEET YEAR ENDED 31 DECEMBER 2020
| FIXED ASSETS Investments 9 CURRENT ASSETS Debtors 10 Net current assets Total assets less current liabilities Funds 11 Unrestricted fund Restricted fund Cash at bank and in hand CREDITORS: amounts falling due within one year Note |
£ £ 4,015,278 0 789,563 789,563 13,977 775,586 4,790,864 4,743,175 47,689 4,790,864 2020 |
£ £ 3,978,691 196,209 843,911 1,040,120 7,059 1,033,061 5,011,752 4,929,670 82,082 5,011,752 2019 |
£ £ 3,978,691 196,209 843,911 1,040,120 7,059 1,033,061 5,011,752 4,929,670 82,082 5,011,752 2019 |
|---|---|---|---|
| 5,011,752 | |||
| 4,929,670 82,082 |
|||
| 5,011,752 |
Approved and authorised for issue by the Trustees on 13 January 2022 and signed on their behalf by
Mrs O Grogono - Chair
The notes on pages 10 to 15 form an integral part of these accounts.
Page 8
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE STATEMENT OF CASH FLOW YEAR ENDED 31 DECEMBER 2020
| STATEMENT OF CASH FLOW YEAR ENDED 31 DECEMBER 2020 |
||||
|---|---|---|---|---|
| Note Net cash generated by operating activities 14 Cash from investing activities Interest and dividends Transfer from stockbroker Cash provided by investing activities Change in cash and cash equivalents in the year Cash and cash equivalents brought forward Cash and cash equivalents carried forward |
93,998 (184,915) |
Total Funds 2020 £ 36,569 (90,917) (54,348) 843,911 789,563 |
118,795 24,645 |
Total Funds 2019 £ (186,597) 143,440 |
| (43,157) 887,068 |
||||
| 843,911 |
Page 9
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020
1. Accounting policies
Basis of preparation and assessment of going concern
The financial statements have been prepared under the historical cost convention, as modified by the revaluation of certain fixed assets, and in accordance with the Statement of Recommended Practice 'Accounting and Reporting by Charities preparing their accounts in accordance with Financial Reporting Standard applicable in the UK and Republic of Ireland' (FRS102), applicable accounting standards and the Charities Act 2011.
The Trust constitutes a public benefit entity as defined by FRS102.
Although the impact of COVID-19 is still uncertain, the Trustees consider that there are no uncertainties about their ability to continue as a going concern as a result of the pandemic or any other matters.
Incoming resources
Donations are accounted for when received by the Trust and legacies are recognised when it is probable that they will be received. Other income is accounted for on an accruals basis as far as it is prudent to do so. Income includes income tax recoverable.
Resources expended
Liabilities are recognised as soon as there is a legal or constructive obligation committing the charity to the expenditure. All expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all costs related to the category.
Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes both costs that can be directly allocated to the activity and indirect costs required to support the work of the charity.
Gifts in kind
The Trust receives the benefit of work carried out by volunteers and is allocated a room at the Centre free of charge. No value is placed on these items.
Taxation
As a registered charity, the trust is exempt from tax as it has no taxable activities. Irrecoverable VAT borne by the Trust is included in the cost of the item to which it relates.
Investments
Investment income is taken into account on the basis of the due date of payment. Investments are a form of basic financial instrument and are initially recognised at their transaction value and subsequently measured at their fair value as at the balance sheet date using the closing quoted market price . All gains and losses, whether realised or unrealised are credited or charged to the Unrestricted Fund.
Fund accounting
Unrestricted income funds are general funds that are available for use at the Trustee's discretion in furtherance of the objectives of the charity.
Restricted funds are those donated for use in a particular area or for a specific purpose, the use of which is restricted to that area.
Details of the nature and purpose of each fund is set out in note 11.
Governance costs
Governance costs include costs of the preparation and examination of the Report and Financial Statement, costs relating to Trustees' meetings and any legal costs relating to governance and constitutional matters.
2. Transactions with Trustees and other connected persons
No transactions took place between the Trust and the Trustees or any persons connected with them.
Page 10
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020
3. Donations and legacies
| Donations Tax refunds Legacies Other activities to generate funds Sale of merchandise Events run by the trust Investment income Dividends from UK listed investments Interest receivable Raising Funds Purchase of items for sale Cost of events run by the Trust |
Unrestricted fund £ 5,714 4,603 10,000 20,317 Unrestricted fund £ 2,096 0 2,096 Unrestricted fund £ 92,843 1,135 93,978 Unrestricted fund £ 1,061 0 1,061 |
Restricted fund £ 53,887 0 0 53,887 Restricted fund £ 0 0 0 Restricted fund £ 0 20 20 Restricted fund £ 0 0 0 2020 2020 2020 2020 |
Total £ 59,601 4,603 10,000 74,204 Total £ 2,096 0 2,096 Total £ 92,843 1,155 93,998 Total £ 1,061 0 1,061 |
Unrestricted fund £ 6,176 0 197,359 203,535 Unrestricted fund £ 3,926 28,645 32,571 Unrestricted fund £ 116,015 2,581 118,596 Unrestricted fund £ 1,357 13,036 14,393 |
Restricted fund £ 83,535 0 120,213 203,748 Restricted fund £ 0 0 0 Restricted fund £ 0 199 199 Restricted fund £ 0 0 0 2019 2019 2019 2019 |
Total £ 89,711 0 317,572 |
|---|---|---|---|---|---|---|
| 407,283 | ||||||
| Total £ 3,926 28,645 |
||||||
| 32,571 | ||||||
| Total £ 116,015 2,780 |
||||||
| 118,795 | ||||||
| Total £ 1,357 13,036 |
||||||
| 14,393 |
4. Other activities to generate funds
5. Investment income
6. Raising Funds
Page 11
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED
31 DECEMBER 2020
7. Details of Charitable Activities
| Grants and Donations Equipment purchased Research salaries Patient therapy Patient amenities Patient grants Research donations Courses training and library Support costs Insurance Emoluments of employee Stockbroker's fees Office cost Governance costs Auditor's remuneration Staff costs Staff costs were as follows: Charge for salaries from University |
Unrestricted fund Restricted fund Total £ £ £ 0 131,816 131,816 10,889 0 10,889 27,293 0 27,293 8,353 3,442 11,795 0 3,441 3,441 0 0 0 6,855 0 6,855 1,002 0 1,002 18,281 0 18,281 23,939 0 23,939 2,813 0 2,813 3,673 0 3,673 103,098 138,699 241,797 Hospitals Bristol NHS Foundation Trust 2020 |
Unrestricted fund £ 0 11,619 0 10,282 0 0 4,295 1,002 18,132 24,992 4,229 3,402 77,953 |
Restricted fund £ 24,919 0 0 10,404 2,415 270,213 0 0 0 0 0 0 307,951 2020 £ 18,281 2019 |
Total £ 24,919 11,619 0 20,686 2,415 270,213 4,295 1,002 18,132 24,992 4,229 3,402 |
|---|---|---|---|---|
| 385,904 | ||||
| 2019 £ 18,132 |
8. Staff costs
Charge for salaries from University Hospitals Bristol NHS Foundation Trust
There was one employee throughout the year. This employee did not receive emoluments of more than £60,000.
No trustees have received any remuneration or reimbursed expenses during the year, nor did any trustee have a disclosable interest in any of the charity's transactions.
Page 12
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED
31 DECEMBER 2020
9. Fixed asset investments
| Fixed interest securities Equity shares Investment trusts and unit trusts Cash Historical cost of listed investments Market value: At 31 December 2019 Additions Disposals Decrease in value in year Transfer from income At 31 December 2020 Listed investments at market value |
Listed investments £ 3,898,250 1,275,628 (1,013,939) (313,028) 0 3,846,911 |
2020 £ 444,350 1,937,410 1,465,151 3,846,911 168,367 4,015,278 3,466,845 Cash £ 80,441 1,178,639 (1,275,628) 0 184,915 168,367 |
2019 £ 369,371 2,110,387 1,418,492 |
|---|---|---|---|
| 3,898,250 80,441 |
|||
| 3,978,691 | |||
| 3,205,159 | |||
| Total £ 3,978,691 2,454,267 (2,289,567) (313,028) 184,915 |
|||
| 4,015,278 |
At 31 December 2020 there was one holding in individual equities that were valued at over 5% of the portfolio value at that date. The holding of 8750 I shares S&P 500 ETF had a market value of £238,153 at the year end.
10. Creditors: amounts falling due within one year
| Accrued expenses Unpaid invoices |
2020 £ 5,883 8,094 13,977 |
2019 £ 7,059 - |
|---|---|---|
| 7,059 |
Page 13
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020
11. Funds
| Funds | |||||
|---|---|---|---|---|---|
| Restricted Funds Unrestricted funds Equipment fund - to purchase and maintain medical equipment Research Fund- to fund research projects Marsden bequest- to fund research salaries General fund Earmarked fund- gifts for other purposes |
At 31 December 2019 £ 34,447 22,042 1,464 24,129 82,082 4,929,670 5,011,752 |
Incoming resources £ 39,486 20 0 14,401 53,907 116,391 170,298 |
Resources expended £ 124,332 0 0 14,367 138,699 252,487 391,186 |
Transfers between funds £ 50,399 0 0 0 50,399 (50,399) 0 |
At 31 December 2020 £ 0 22,062 1,464 24,163 |
| 47,689 4,743,175 |
|||||
| 4,790,864 |
The Trustees maintain separate bank deposits for each of the above funds, to ensure that sufficient resources are available to be applied.
12. Analysis of net assets between funds
| Investments Current assets 13. Commitments Courses for hospital staff Information support and research salaries Chemotherapy and treatment chairs Gamma knife checking system Radiation dose checking software Blood gas analyser Radiotherapy planning trial Fatigue app development TYA complimentary therapies 3D printer Examination couches Fans At 31 December 2020 the trust had entered into the following commitments. Creditors due within one year |
Unrestricted Funds £ 4,015,278 741,874 (13,977) 4,743,175 |
Restricted Funds £ 0 47,689 0 47,689 |
Total Funds 2020 £ 4,015,278 789,563 (13,977) |
|---|---|---|---|
| 4,790,864 | |||
| £ 16,000 11,500 12,000 9,549 6,998 30,150 8,500 4,586 64,800 43,000 4,690 8,946 |
Page 14
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED
31 DECEMBER 2020
14. Reconciliation of net movement in funds to cash flow from operating activities
| Reconciliation of net movement in funds to cash flow from operating activities | ||
|---|---|---|
| Net movement in funds Less investment income Less gains on investments Decrease/(increase) in debtors (Decrease)/increase in creditors Net cash generated by operating activities |
2020 £ (220,888) (93,998) 148,328 196,209 6,918 36,569 |
2019 £ 736,113 (118,795) (577,761) (193,960) (32,194) |
| (186,597) |
Page 15